Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiotoxicity of Aluminum Phosphide Poisoning; Biochemical and Electrophysiological Studies and the Utility of Tropinin and CKmb as Early Biomarkers

NCT04191265 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04191265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04191265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiotoxicity of Aluminum Phosphide Poisoning; Biochemical and Electrophysiological Studies and the Utility of Tropinin and CKmb as Early Biomarkers
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
December 5, 2019
Completion date
June 5, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aluminum phosphid poisoning, cardiotoxicity